120 related articles for article (PubMed ID: 38702504)
1. Author Correction: Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status.
Kim MY; Park ER; Cho EH; Park SH; Han CJ; Kim SB; Gu MB; Shin HJ; Lee KH
Sci Rep; 2024 May; 14(1):10202. PubMed ID: 38702504
[No Abstract] [Full Text] [Related]
2. Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status.
Kim MY; Park ER; Cho EH; Park SH; Han CJ; Kim SB; Gu MB; Shin HJ; Lee KH
Sci Rep; 2024 Apr; 14(1):7997. PubMed ID: 38580756
[TBL] [Abstract][Full Text] [Related]
3. Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1).
Liu L; Liu A; Dong J; Zuo Z; Liu X
Exp Cell Res; 2022 Apr; 413(2):113075. PubMed ID: 35192838
[TBL] [Abstract][Full Text] [Related]
4. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.
Okumura T; Ikeda K; Ujihira T; Okamoto K; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2018 Jan; 163(1):19-29. PubMed ID: 28992264
[TBL] [Abstract][Full Text] [Related]
5. Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy.
Adler J; Oren R; Shaul Y
Cancer Med; 2023 May; 12(9):10781-10790. PubMed ID: 36934426
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.
Frum RA; Love IM; Damle PK; Mukhopadhyay ND; Palit Deb S; Deb S; Grossman SR
Mol Cancer Res; 2016 May; 14(5):423-36. PubMed ID: 26965143
[TBL] [Abstract][Full Text] [Related]
7. Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Bencomo-Alvarez AE; Rubio AJ; Olivas IM; Gonzalez MA; Ellwood R; Fiol CR; Eide CA; Lara JJ; Barreto-Vargas C; Jave-Suarez LF; Nteliopoulos G; Reid AG; Milojkovic D; Druker BJ; Apperley J; Khorashad JS; Eiring AM
Oncogene; 2021 Apr; 40(15):2697-2710. PubMed ID: 33712704
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of Psmd1 controls Adrm1 interaction with the proteasome.
Ryu H; Gygi SP; Azuma Y; Arnaoutov A; Dasso M
Cell Rep; 2014 Jun; 7(6):1842-8. PubMed ID: 24910440
[TBL] [Abstract][Full Text] [Related]
9. NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1.
Craxton A; Butterworth M; Harper N; Fairall L; Schwabe J; Ciechanover A; Cohen GM
Cell Death Differ; 2012 Sep; 19(9):1424-34. PubMed ID: 22361683
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
An WG; Chuman Y; Fojo T; Blagosklonny MV
Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
[TBL] [Abstract][Full Text] [Related]
11. ATG16 mediates the autophagic degradation of the 19S proteasomal subunits PSMD1 and PSMD2.
Xiong Q; Fischer S; Karow M; Müller R; Meßling S; Eichinger L
Eur J Cell Biol; 2018 Nov; 97(8):523-532. PubMed ID: 30269947
[TBL] [Abstract][Full Text] [Related]
12. Analysis and experimental validation of the innate immune gene PSMD1 in liver hepatocellular carcinoma and pan-cancer.
Chen X; Liu G; Wu B
Heliyon; 2023 Nov; 9(11):e21164. PubMed ID: 37928041
[TBL] [Abstract][Full Text] [Related]
13. PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1.
Liu L; Liu A; Liu X
Transl Oncol; 2023 Jan; 27():101586. PubMed ID: 36379103
[TBL] [Abstract][Full Text] [Related]
14. PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.
Tan Y; Jin Y; Wu X; Ren Z
BMC Mol Biol; 2019 Nov; 20(1):24. PubMed ID: 31703613
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.
Lee EW; Lee MS; Camus S; Ghim J; Yang MR; Oh W; Ha NC; Lane DP; Song J
EMBO J; 2009 Jul; 28(14):2100-13. PubMed ID: 19536131
[TBL] [Abstract][Full Text] [Related]
16. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
17. PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
Park HC; Kim H; Kim JY; Lee HY; Lee J; Cha W; Ahn SH; Jeong WJ
BMC Cancer; 2023 Dec; 23(1):1242. PubMed ID: 38104103
[TBL] [Abstract][Full Text] [Related]
18. Association of intronic polymorphisms (rs1549339, rs13402242) and mRNA expression variations in PSMD1 gene in arsenic-exposed workers.
Ahmad S; Arif B; Akram Z; Ahmed MW; Khan AU; Hussain MZ; Rahman F; Kayani MA; Mahjabeen I
Environ Sci Pollut Res Int; 2020 Apr; 27(10):11425-11437. PubMed ID: 31965495
[TBL] [Abstract][Full Text] [Related]
19. RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.
Xie S; Hong Z; Li Y; Wang J; Wang J; Li S; Liu Y
Mol Neurobiol; 2022 Aug; 59(8):4703-4717. PubMed ID: 35594003
[TBL] [Abstract][Full Text] [Related]
20. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73.
Peschiaroli A; Scialpi F; Bernassola F; Pagano M; Melino G
Oncogene; 2009 Sep; 28(35):3157-66. PubMed ID: 19581926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
